CIK 0001041024
- Non-accelerated filer
- Smaller reporting company
ROCKWELL MEDICAL, INC.
Sign in to watch- Ticker
- RMTI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383317208
- Phone
- +1 800-449-3353
- Business address
- 30142 WIXOM ROAD, WIXOM, MI, 48393
- Former names
- ROCKWELL MEDICAL TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,420
- in 1 filing, $8K under 10b5-1 plans
Net −$8,420. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-30 | Richmond David S. 10% owner | Purchase | +9,946 | $1.92 | $19K | 96,255 |
| 2020-06-30 | Richmond David S. 10% owner | Purchase | +7,526 | $1.92 | $14K | 103,781 |
| 2020-06-11 | McGarry Paul E Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2020-06-11 | Nissenson Allen Director | Grant or award | +23,000 | 23,000 | ||
| 2020-06-11 | Nissenson Allen Director | Grant or award · Stock Option (Right to Buy) | +34,639 | 34,639 | ||
| 2020-05-18 | RAVICH MARK H Director | Grant or award | +30,800 | 387,509 | ||
| 2020-05-18 | RAVICH MARK H Director | Grant or award · Stock Option (Right to Buy) | +34,024 | 34,024 | ||
| 2020-05-18 | MCLAUGHLIN JOHN PETER Director | Grant or award | +51,800 | 86,974 | ||
| 2020-05-18 | MCLAUGHLIN JOHN PETER Director | Grant or award · Stock Option (Right to Buy) | +34,024 | 34,024 | ||
| 2020-05-18 | COOPER JOHN G Director | Grant or award | +36,000 | 55,879 | ||
| 2020-05-18 | COOPER JOHN G Director | Grant or award · Stock Option (Right to Buy) | +34,024 | 34,024 | ||
| 2020-05-18 | Radie Robert S Director | Grant or award | +31,000 | 34,689 | ||
| 2020-05-18 | Radie Robert S Director | Grant or award · Stock Option (Right to Buy) | +34,024 | 34,024 | ||
| 2020-05-14 | ELLISON RUSSELL H See Remarks | Purchase | +2,000 | $2.08 | $4K | 12,050 |
| 2020-04-26 | Pratt Raymond Dennis VP of Drug Development | Shares withheld for taxes | −4,612 | $2.27 | $10K | 353,358 |
| 2020-04-26 | Gupta Ajay Sr. VP & Chief Scientific Off. | Shares withheld for taxes | −1,758 | $2.27 | $4K | 574,700 |
| 2020-04-17 | ELLISON RUSSELL H See Remarks | Grant or award · Stock Option (Right to Buy) | +600,000 | 600,000 | ||
| 2020-04-17 | ELLISON RUSSELL H See Remarks | Grant or award · Stock Option (Right to Buy) | +600,000 | 600,000 | ||
| 2020-03-31 | Radie Robert S Director | Grant or award | +3,689 | 3,689 | ||
| 2020-03-31 | Radie Robert S Director | Grant or award · Stock Option (Right to Buy) | +6,148 | 6,148 |
Page 10 of 20 · 382 trades